Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New biomarkers in SLE: from bench to bedside.
Capecchi R, Puxeddu I, Pratesi F, Migliorini P. Capecchi R, et al. Rheumatology (Oxford). 2020 Dec 5;59(Suppl5):v12-v18. doi: 10.1093/rheumatology/keaa484. Rheumatology (Oxford). 2020. PMID: 32911542 Free PMC article. Review.
IL-1 family cytokines and receptors in IgG4-related disease.
Capecchi R, Italiani P, Puxeddu I, Pratesi F, Tavoni A, Boraschi D, Migliorini P. Capecchi R, et al. Cytokine. 2018 Feb;102:145-148. doi: 10.1016/j.cyto.2017.08.001. Epub 2017 Aug 18. Cytokine. 2018. PMID: 28823915
Mediators of angiogenesis and fibrosis in IgG4-related disease.
Puxeddu I, Capecchi R, Pratesi F, Cianchetti S, Tavoni A, Migliorini P. Puxeddu I, et al. Among authors: capecchi r. Clin Exp Med. 2018 May;18(2):245-249. doi: 10.1007/s10238-017-0484-z. Epub 2017 Dec 14. Clin Exp Med. 2018. PMID: 29243036
Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review.
Puxeddu I, Capecchi R, Carta F, Tavoni AG, Migliorini P, Puxeddu R. Puxeddu I, et al. Among authors: capecchi r. J Immunol Res. 2018 Apr 1;2018:6936727. doi: 10.1155/2018/6936727. eCollection 2018. J Immunol Res. 2018. PMID: 29805984 Free PMC article. Review.
Renal Involvement in IgG4-Related Disease: From Sunlight to Twilight.
Capecchi R, Giannese D, Moriconi D, Bonadio AG, Pratesi F, Croia C, Egidi MF, Puxeddu I, Tavoni AG, Migliorini P. Capecchi R, et al. Front Med (Lausanne). 2021 Mar 31;8:635706. doi: 10.3389/fmed.2021.635706. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33869249 Free PMC article.
Ig Glycosylation in Ulcerative Colitis: It's Time for New Biomarkers.
Capecchi R, Migliorini P, Zanzi F, Maltinti S, Puxeddu I, de Bortoli N, Bellini M, Costa F, Marchi S, Bertani L. Capecchi R, et al. Front Pharmacol. 2021 Apr 9;12:654319. doi: 10.3389/fphar.2021.654319. eCollection 2021. Front Pharmacol. 2021. PMID: 33897440 Free PMC article.
Two Takayasu arteritis patients successfully treated with rituximab.
Caltran E, Di Colo G, Ghigliotti G, Capecchi R, Catarsi E, Puxeddu I, Migliorini P, Tavoni A. Caltran E, et al. Among authors: capecchi r. Clin Rheumatol. 2014 Aug;33(8):1183-4. doi: 10.1007/s10067-014-2506-5. Epub 2014 Jan 31. Clin Rheumatol. 2014. PMID: 24478126
CXCL12/SDF-1 in IgG4-Related Disease.
Capecchi R, Croia C, Puxeddu I, Pratesi F, Cacciato A, Campani D, Boggi U, Morelli L, Tavoni A, Migliorini P. Capecchi R, et al. Front Pharmacol. 2021 Oct 26;12:750216. doi: 10.3389/fphar.2021.750216. eCollection 2021. Front Pharmacol. 2021. PMID: 34764871 Free PMC article.
One year in review 2017: pathogenesis of rheumatoid arthritis.
Angelotti F, Parma A, Cafaro G, Capecchi R, Alunno A, Puxeddu I. Angelotti F, et al. Among authors: capecchi r. Clin Exp Rheumatol. 2017 May-Jun;35(3):368-378. Epub 2017 Jun 7. Clin Exp Rheumatol. 2017. PMID: 28631608 Free article. Review.
16 results